Abstract:Objective: To investigate the effect and mechanism of emodin (EMO) on human pancreatic cancer cell line BxPC-3 in vivo. Methods: After the pancreatic cancer model in nude mice was established, the mice were divided into four groups: control group (NS 0.2mL/d by i.p. injection), EMO group (EMO 40mg?kg-1?d-1 by i.p. injection), and Gemcitabine (GEM) group (GEM 80mg/kg, twice/week by i.p. injection) with 8 mice each group. After 2 weeks of administration, the mice were sacrificed, detected the body-weight change of nude nice before and after the experiment, and recorded the growth inhibition rate of tumor (TGI). Immunohistochemical (IHC) staining for ki-67 and terminal deoxynucleotidyl transferase-mediated nicked labeling assay (TUNEL) were undertaken to detect the cell proliferation and cell apoptosis in tumor tissue in xenograft nude mice. Results: The inter-group comparisons in body-weight of nude mice showed no significant difference in comparing group NS(27.0±1.64)g with group EMO(25.1±1.58)g and GEM(25.6± 1.47)g.The EMO group was 38.46%, the GEM group was 44.23%. The inter-group comparisons in immunohistochemical analysis of ki-67 showed significant difference in comparing group NS IOD(219.5±17.98) with group EMO IOD(146.6± 11.57)and GEM IOD(139.5±12.55), (P0.01), and the expression of ki-67 in EMO and GEM groups were lower than that in NS group, P0.05; while the expression of ki-67 between EMO and GEM groups showed no significant difference. The inter-group comparisons in TUNEL analysis showed significant difference in comparing group NS IOD(23.6±6.02) with group EMO IOD(65.7±4.97)and GEM IOD(67.4±5.59), (P0.01), and the TUNEL-positive cells in EMO and GEM groups were higher than that in NS group; while the TUNEL-positive cells between EMO and GEM groups showed no significant difference. Conclusion: Emodin can inhibit the growth of pancreatic cancer cells BXPC-3 in nude mice; and this affection was achieved by suppressing cell proliferation and inducing cell apoptosis.

Research Progress of the Anti-Proliferation Effect of Emodin on VSMCs

[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].

Sbudies on the Effect of Parthenolide on the Proliferation of Rat Vascular Smooth Muscle Cells and the Mechanism

Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II.

Anti-tumor Activity of Emodin on Human Pancreatic Cancer Cell Line BXPC-3 in Vivo

Effect of Emodin on Expression of CyclinD1 of Human Vascular Smooth Muscle Cells

Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.

A Survey of Recent Studies on Pharmacology of Emodin

Involvement of p53-dependent pathway in the antiproliferative activity of emodin in human smooth muscle cell]

Advances in Research on Anti-tumor Activity and Related Mechanisms of Emodin

Research progress on curcuma zedoary extracts inhibiting vascular smooth muscle cell proliferation in pathological process of in-stent restenosis

Immunosuppressive Effects of Emodin: An In Vivo and In Vitro Study

Inhibitory Effect of Emodin on Human Colon Cancer SW620 Cells and Possible Mechanisms

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug

Research Progress of Emodin Anti-Gallbladder Carcinoma

The possible mechanism of inhibiting smooth muscle cell proliferation by Emodin

Effect of Proliferation and Cell Cycle of Febrifugal and Antipyic Drugs on Vascular Smooth Muscle Cells

[Synthesis of Emodin Derivatives and Their Inhibiting Effects on Proliferation of Leukemia Cell Lines].

Design and Synthesis of Novel Anti-Proliferative Emodin Derivatives and Studies on Their Cell Cycle Arrest, Apoptosis Pathway and Migration

Inhibitory Effects of Emodin on Proliferation of Human Lymphocytes in Vitro

Emodin Suppresses the Migration and Invasion of Melanoma Cells